Ansell Cap Corp (ANCCF) 0.1525 $ANCCF
BriaCell Therapeutics Announces Closing of Go-Public Onto Toronto Stock Exchange Venture, Closing of Concurrent Financing With Agents Sunel Securities and M Partners, Closing of Hospital Partnership and Royalty Relinquishment Corporate Update
GlobeNewswire - Wed Dec 03, 11:26AM CST
BriaCell Therapeutics Corp (TSX-V:BCT) ("BriaCell", the "Company", or "BCT"

is pleased to announce that it has, effective December 1, 2014, completed its Go-Public Event onto the Toronto Stock Exchange Venture (the "Go-Public"

and concurrent financing (the "Financing"

(together referred to as the "Transaction"

with Ansell Capital Corp ("Ansell"

. The Company's shares are now trading under the symbol BCT. The terms of the Go-Public Event, which was structured as a Reverse Takeover ("RTO"

under the rules and policies of the TSX Venture Exchange (the "TSX-V"

, were previously announced by the Company in a release dated April 17, 2014. The Transaction was approved by 100.00% of shareholders. At a deemed value of $0.18 the Company's market value is approximately $15 million.
BCT.VN: 0.160 (unch)
IIROC Trading Resumption - BCT
CNW Group - Tue Dec 02, 3:12PM CST
Trading resumes in: